Search for: "General Chemical Performance Products L L C" Results 61 - 80 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2013, 1:02 am by W.F. Casey Ebsary, Jr.
Because Schedule I is the most restricted drug classification under the CSA, the production, sale, and use of marijuana are largely banned by federal law. [read post]
23 Jan 2013, 1:02 am by W.F. Casey Ebsary, Jr.
Because Schedule I is the most restricted drug classification under the CSA, the production, sale, and use of marijuana are largely banned by federal law. [read post]
24 Jan 2022, 8:38 am by Katherine Pompilio
The discussion will be moderated by Brookings senior fellow Daniel L. [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the importation of… [read post]
19 Sep 2011, 9:36 am by Schachtman
  The Supreme Court’s decision in Daubert changed practice by holding that Rule 702 required gatekeeping, and by generally slighting Rule 703. [read post]
The rule will address HFCs in three ways: (1) phasing down production and consumption, (2) maximizing reclamation and minimizing releases from equipment, and (3) facilitating the transition to next-generation technologies through sector-based restrictions. [read post]
The rule will address HFCs in three ways: (1) phasing down production and consumption, (2) maximizing reclamation and minimizing releases from equipment, and (3) facilitating the transition to next-generation technologies through sector-based restrictions. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
23 May 2009, 11:26 am
SLT, and most likely other chemical mediators, attach to receptors on the inside surface of blood vessel cells (endothelial cells) and initiate a chemical cascade that results in the formation of tiny thrombi (blood clots) within these vessels. [read post]
6 Dec 2009, 9:11 pm by smtaber
The court threw new obstacles Friday in front of the Sevier Power Co. by requiring a substantial updating of its air-pollution permit for a 270-megawatt, $600 million electric generator in Sigurd. [read post]
1 Feb 2012, 9:15 am by SteinMcewen, LLP
  Thus, the new prior user defense will likely benefit those users who are performing experimental or pre-commercial uses as opposed to those users who are actually commercializing the invention. 35 U.S.C. [read post]